Investment Stage

Focus Areas

About Investor

Renjie Wang is a Managing Director on the Bain Capital Life Sciences team, based in Shanghai. She invests in healthcare and life sciences companies across Greater China, including pharmaceuticals, biotechnology, medical devices, and healthcare services, with a focus on growth and buyout-style transactions. The check sizes linked to her activity sit roughly in the $1M to $100.0M range. Before joining Bain Capital in 2014, she worked at Hony Capital on healthcare buyouts, minority growth investments, and privatizations, and she holds a master’s in finance from Peking University and a BA in economics from Fudan University.